GrEPaFI(

!"
!"#$%&'()(Méthodologie+:+propositions+issues+du+groupe+de+pilotage()(*+,-+./"+(0123(
(
GrEPaFI(
#$%&'(")*+,&)("'-$".-,/(0,1"2/3,/41"
(
+
+
+
+
511(116(0,"%4"#(0($-7"'$-3,/,/%00($1"8"-"1,&)9"&1/0:"1,-0)-$)/;()"
'-,/(0,"6(,<%)"
Méthode(du(«(patient(standardisé(»((
Concept(
$45"(678"'"+(94*(,"%-':5+*(,"4;+**'499+<<+*=(<+*(.7->46+*(<+*(,<5*(5-'<'*7+*(+9(&"%98+(*49-(<+*(.7->46+*(
'96'"+8-+*(678<%"%-'?+*(@%56'-*(6+(64**'+"*=(:5+*-'499%'"+*=(?'A9+--+*(8<'9':5+*BC(:5'(nous renseignent sur «
ce que les praticiens déclarent faire » et non sur « ce qu’ils font ».
La méthode « patient standardisé » consiste en une simulation de consultation, où un patient formé à
« jouer » une situation clinique de façon précise, fiable et reproductible, analyse le comportement des
praticiens directement sur leur lieu d’exercice habituel.
Le médecin est en aveugle, et le patient standardisé est formé à recueillir les données de la consultation de
façon précise, fiable et reproductible : ainsi sont décrites précisément les réactions, les stratégies, les
explorations des professionnels selon une grille établie par le comité scientifique, face à une situation
médicale donnée.
Cependant, cette méthode, très utilisée dans d’autres pays, a ses exigences méthodologiques : une
standardisation méticuleuse de la situation clinique et un maintien de l’aveugle. (
Petit(historique(de(la(méthode((
D7?+<4,,7+( 6%9*( <+*( %997+*( E1( ,%"( <+( 9+5"4<4A5+( %.7"'8%'9( FG( H%""4I*=( ,45"( ;4".+"( +-( 7?%<5+"( <+*(
'9-+"9+*( +J+"K%9-( 6%9*( *49( *+"?'8+=( <%( .7->46+( +*-( ,"4A"+**'?+.+9-( .'*+( %5( ,4'9-=( ,+%5;'97+=( ?%<'67+=(
,4,5<%"'*7+=( ,45"( 6+?+9'"( 6%9*( <+*( %997+*( L1MN1=( 59( 45-'<( ,76%A4A':5+( '9849-45"9%/<+( 5-'<'*7( 6%9*( <%(
,<5,%"-(6+*(;%85<-7*(6+(O76+8'9+(P4"6MQ.7"'8%'9+*R(
$%"%<<S<+.+9-=( T( ,%"-'"( 6+*( %997+*( L1=( <%( .7->46+( 84..+98+( T( U-"+( 5-'<'*7+( %5J( #-%-*MV9'*( 6%9*(
<W7?%<5%-'49(6+*(,"%-':5+*(,"4;+**'499+<<+*R(X%(,5'**%98+(6+(8+-(45-'<(;%'-(:5W'<(*W'.,4*+("%,'6+.+9-(84..+(
<+(A4<6M*-%96%"6(,45"(678"'"+(<+*(,"%-':5+*(6+*(.76+8'9*R(
Q( ,%"-'"( 6+*( %997+*( N1=( 6+( 94./"+5*+*( 7-56+*( *49-( ,5/<'7+*( +9( #5"4,+( +-( 94-%..+9-( %5J( $%Y*MH%*=(
?%<'6%9-(*49(5-'<'*%-'49=(+-(%;;'9%9-=(%.7<'4"%9-(%5(,%**%A+(<%(.7->464<4A'+R(
Z+(9W+*-(:5W+9(011E(:5+(<+*(6+5J(,"+.'S"+*(7-56+*([($%-'+9-*(G-%96%"6'*7*(\(*49-(,5/<'7+*(+9(&"%98+=(<W59+(
7?%<5%9-(<%(,"'*+(+9(8>%"A+(6+(<W>Y,+"-+9*'49(%"-7"'+<<+(+-(6+(<W'9;%"8-5*(65(.Y48%"6+(8>+](<+*(8%"6'4<4A5+*(
<'/7"%5J=(<W%5-"+(<%(6'*,+9*%-'49(6+(,'<5<+(65(<+96+.%'9(8>+](<+*(,>%".%8'+9*(6W4;;'8'9+*R(
(

="
!"#$%&'()(Méthodologie+:+propositions+issues+du+groupe+de+pilotage()(*+,-+./"+(0123(
(
P45*(*45>%'-49*(.+--"+(+9(,<%8+(59(-+<(6'*,4*'-';(%5(*+'9(65(67,%"-+.+9-(6+(.76+8'9+(A797"%<+(6+($%"'*M
D'6+"4-(%;'9(6+(.5<-',<'+"(<+*(-"%?%5J(5-'<'*%9-(8+--+(.7->46+(T(<W%'6+(6W59+(,"48765"+(/'+9(*-"58-5"7+R(X%(
*5'-+(6+(8+(6485.+9-(+J,<':5+(<+*(,"'98',+*(.7->464<4A':5+*(:5+(945*(%<<49*(%,,<':5+"R(
Recrutements(des(investigateurs(et(des(patients(
Recrutement(des(généralistes(
>%&,"6+)(3/0"6%,/?+(,%"(<+(,"4^+-(+-(%88+,-%9-(6+(945?+%5J(,%-'+9-*(T(*%(849*5<-%-'49(@8;R(détectionC(,+5-(
U-"+('98<5*(6%9*(<W7-56+($%-'+9-(G-%96%"6'*7R(
D%9*(59(,"+.'+"( -+.,*=(<+*(,"%-'8'+9*(65([("7*+%5(\(65(D7,%"-+.+9-(6+(O76+8'9+(!797"%<+(@.%'-"+*(6+(
*-%A+*=(+9*+'A9%9-*BC(6+($%"'*MD'6+"4-(*49-(<+*(,"'98',%5J(,"%-'8'+9*(*4<<'8'-7*R(
Q(-+".+=(<+*(7-56+M;4".%-'49*(,45""49-(U-"+(45?+"-+*(T(6W%5-"+*("7*+%5J(6+(A797"%<'*-+*=(94-%..+9-(%5J(
%5-"+*(&%85<-7*(6+(O76+8'9+(,%"'*'+99+*(6%9*(<+(8%6"+(6+('$%@(,1"/0,($A4-31R(
V9( 3%01(0,(6(0,( 78"'-( 64'-( U-"+( *'A97( ,%"( <+( ,"%-'8'+9=( %?%9-( <+( 67/5-( 6+( <W7-56+=( +-( 59( 8+"-%'9( 94./"+(
6W'9;4".%-'49*(,"%-':5+*(64'?+9-(U-"+("+9*+'A97+*(,45"(<+(/49(67"45<+.+9-(6+(<W7-56+=(94-%..+9-(_((
! G'(6+(945?+%5J(,%-'+9-*(*49-(%88+,-7*(45(949R(
! X+*(>4"%'"+*(6+(,"7*+98+(*5"(<+(<'+5(6+(849*5<-%-'49R(
! X%(,"7*+98+(6+(84<<%/4"%-+5"*(*5"(<+(<'+5(6W+J+"8'8+R(
! B(
Recrutement(des(patients(standardisés(
B(1"+,&)/-0,1"6%,/?+1(,%"(<W7?%<5%-'49(6+*(,"%-':5+*(+9(.76+8'9+(A797"%<+((^45+"49-(<+*(,%-'+9-*(*'.5<7*R(
X+5"( ,%"-'8',%-'49( %5( ,"4^+-=( <W%9%<Y*+( 6+*( "7*5<-%-*=( ,45""49-( 849*-'-5+"( -45-( 45( ,%"-'+( 6+( <+5"( ->S*+(
6W+J+"8'8+R(
Z+( 8>4'J( ,"7*+9-+( 6+*( %?%9-%A+*( 949( 97A<'A+%/<+*=( 94-%..+9-( *5"( <+( ,<%9( ;'9%98'+"( @/797?4<%-(`C=( .%'*(
,"7*+9-+(7A%<+.+9-(6+*('9849?79'+9-*=(94-%..+9-(,%"8+(:5W'<*(*49-(59+(,4,5<%-'49(*45?+9-(^+59+(+-(+9(
/499+(*%9-7=(8+(:5'(<'.'-+(<+*(->7.%-':5+*(+J,<4'-%/<+*R(
Q( -+".+=( <+( "+845"*( T( 6+*( 3%6+)/(01" '$%4(11/%00(71" %&" 0%0( ,45""%'-( *W'.,4*+"( *45*( 845?+"-( 6+(
;'9%98+.+9-R((
Sélection(d’un(projet(de(recherche(
>%&," 6+)(3/0"6(6C$(" )&" '$%@(,",+5-( ,"4,4*+"( 59( ->S.+( 6W7-56+( ,%"( ?4'+( 7<+8-"49':5+R( a45-+;4'*( <+(
94./"+( 6W7-56+*( "7%<'*%/<+*( *+"%( <'.'-7=( 6%9*( 59( ,"+.'+"( -+.,*=( T( 6+5J( 7-56+*( ,%"( %9R( X%( *7<+8-'49( 6+*(
6+5J(,"4^+-*(T(.+9+"('984./+(%5(3%6/,+")("'/7%,-:((!"#$%&'R"
X+*(,"4^+-*(*7<+8-'4997*(64'?+9-(U-"+("7%<'*%/<+*(%?+8(<+*(.4Y+9*(%8-5+<*(65(!"#$%&'(@<+(*879%"'4(64'-(U-"+(
,+9*7(,45"(U-"+( "+,"7*+9-7( ,%"( 59( '9-+"9+=(<%(*'-5%-'49( .76'8%<+( 64'-( *+(,"U-+"(T( 59+( 7?%<5%-'49( +9( 59+(
849*5<-%-'49( 59':5+C( +-( 978+**'-+"( 59+( .+*5"+( ,"78'*+( 6+*( 84965'-+*( ,"4;+**'499+<<+*R

D"
!"#$%&'()(Méthodologie+:+propositions+issues+du+groupe+de+pilotage()(*+,-+./"+(0123(
(
(
Protocole(de(l’étude(
Production(du(scénario(:(comité(scientifique(
X+( *879%"'4( 67?+<4,,7( 64'-( 67845<+"( 6'"+8-+.+9-( 6+( <W4/^+8-';( 6+( <W7-56+(b( '<( 64'-( U-"+( %6%,-7( T( 8>%:5+(
->S.+(6+("+8>+"8>+=(+-(,+".+--"+(<W7?%<5%-'49(6+*(,"%-'8'+9*(*5"(<%(*'-5%-'49(64997+R(
X+(*879%"'4(64'-(U-"+(3%<+$(0,(+-($+-7/1,("_(6+*(7<7.+9-*(6+(<%(/'4A"%,>'+(45(65(,%**7(.76'8%<(6+*(,%-'+9-*(
*-%96%"6'*7*(,45""49-(45(6+?"49-(.U.+(U-"+('9-7A"7*(@+J+.,<+(_(59+(8'8%-"'8+(6W%,,+96'8+8-4.'+(4/<'A+(T(
'98<5"+(<W%,,+96'8'-+(6%9*(<+*(%9-7876+9-*CR(
#9;'9=(<+(*879%"'4(64'-(U-"+(<+(,<5*(3%6'7(,(,4**'/<+(_(,"7?4'"(-45*(<+*(7<7.+9-*(6+(<W'6+9-'-7(65(,+"*499%A+(
^457(@94.*=(844"64997+*=(%9-7876+9-*=(.46+(6+(?'+BC=(,"7?4'"(6+*("7,49*+*(%6%,-7+*(+-(*-%96%"6'*7+*(T(
-45-+*(<+*(:5+*-'49*(:5+(<+*(,"%-'8'+9*(,45""%'+9-(,4-+9-'+<<+.+9-(,4*+"R(c<(*W%A'-(<T(+984"+(6+(?+'<<+"(T(<%(
*-%96%"6'*%-'49( 65( "d<+=( <+( ,%-'+9-( *-%96%"6'*7( 9+( 64'-( ,%*( *+( "+-"45?+"( T( '.,"4?'*+"( 6+*( "7,49*+*( 949(
,"7?5+*(,%"(<+(*879%"'4R(#9(;498-'49(6+*(->S.+*(6+("+8>+"8>+*(%/4"67*=(6+*(7<7.+9-*(*48'485<-5"+<*(6'?+"*(
+-(?%"'7*(,45""49-(U-"+('98<5*(%5(*879%"'4R(
X+(*879%"'4(+*-("76'A7(,%"(59(6+*(%5-+5"*(,"'98',%5J(6+(<W7-56+=(,5'*("77?%<57(,%"(59(3%6/,+"13/(0,/4/E&(=(
+-(+9;'9("+?5(T(<W'**5(6+*(849*5<-%-'49*(-+*-*(@8;R(Formation+du+PSC=(8+<<+*M8'(%Y%9-(,5(,+".+--"+(6+(.+--"+(
+9(<5.'S"+(6+*('984>7"+98+*(45(6+*(.%9:5+.+9-*(6%9*(<+(*8"',-R(
Production(de(la(check=list(:(comité(scientifique(
X+(,"'98',+(6+(<%(.7->46+($%-'+9-(G-%96%"6'*7('.,<':5+(<+("+85+'<(6+*(64997+*(6+(<%(849*5<-%-'49R(c<(*W%A'-(
6498=(+9(;498-'49(65(->S.+(6+(8>%:5+(7-56+=(6+()+3$/$("7(1"-3,/%01")(1"'$-,/3/(01R((
$%"(+J+.,<+=(,45"(59+(*'-5%-'49(64997+=(,45"(<%:5+<<+('<(+J'*-+(6+*("+84..%96%-'49*(6+(/499+*(,"%-':5+*=(
49(,+5-(5-'<'*+"(<+*(%8-'49*(,"7849'*7+*(,%"(<+*("+84..%96%-'49*(84..+(-"%.+(,45"(67;'9'"(<+*(8"'-S"+*(T(
7?%<5+"R(
D%9*(-45*(<+*(8%*=(8+--+(,"+.'S"+(<'*-+(6+(8"'-S"+*(6+?"%(U-"+("+6'*85-7+(+-(7?+9-5+<<+.+9-(84.,<7-7+(,%"(
<+(3%6/,+"13/(0,/4/E&(=(849*-'-57(6+*(.+./"+*(65(84.'-7(6+(,'<4-%A+(+-(7?+9-5+<<+.+9-(6+(*,78'%<'*-+*(45(
6W+J,+"-*(65(*5^+-(8498+"97R(
X%( <'*-+( 6+*( 8"'-S"+*( ,45""%( 7?+9-5+<<+.+9-( U-"+( "77?%<57+( %,"S*( "+85+'<( 6+*( 64997+*( ,45"( Y( '98<5"+( 6+*(
%8-'49*(949(,"7?5+*('9'-'%<+.+9-(:5W%5"%'+9-(,"7*+9-7+*(<+*(,"%-'8'+9*R((
Formation(du(patient(standardisé(:(consultations(tests(
X+($G(64'-(U-"+(8%,%/<+(6+(@%&($"4/)F7(6(0,"7(($G7((67?+<4,,7(6%9*(<+(*879%"'4(+-(6+($(3&(/77/$"7(1")%00+(1(
6+(<%(849*5<-%-'49(6+(;%K49(;'%/<+R((
D+*( *7%98+*( [(6W+9-"%'9+.+9-(\(_( <+*( [(3%01&7,-,/%01" ,(1,1(\( *+"49-( 6498( +;;+8-57+*( %?%9-( <+( 67/5-( 6+(
<W7-56+=( %?+8( <W%'6+( 6W59( 4/*+"?%-+5"( +J-7"'+5"=( :5'( *W%**5"+"%( :5+( <%( *-%96%"6'*%-'49( +*-( +;;+8-'?+( +-(
%5-4"'*+"%(<+($G(T(67/5-+"(<W7-56+R(

H"
!"#$%&'()(Méthodologie+:+propositions+issues+du+groupe+de+pilotage()(*+,-+./"+(0123(
(
D+*(849*5<-%-'49*(-+*-*(,45""49-(7A%<+.+9-(U-"+("7%<'*7+*(+9(;'9(6W7-56+(%;'9(6+(?7"';'+"(:5+(<+($G(+*-("+*-7(
;'%/<+R((
(
Les(consultations(:(recueil(des(données(
V9+(;4'*(;4".7(+-(;'%/<+=(<+($G(,+5-(*+(<%98+"(6%9*(<+*(849*5<-%-'49*(6W7?%<5%-'49R(c<(<5'(*+"%("+.'*(_(
! X%(<'*-+(6+*(,"%-'8'+9*(T(?'*'-+"(_(844"64997+*=(>4"%'"+*=(%/*+98+*(7?+9-5+<<+*B(
! X%(*4..+(6W%"A+9-(978+**%'"+(%5(,%'+.+9-(6+*(849*5<-%-'49*(
! #?+9-5+<<+.+9-=( +9( ;498-'49( 65( ->S.+( 6+( <W7-56+=( 6+*( 6485.+9-*( .76'8%5J( @/'4<4A'+=( '.%A+"'+=(
84.,-+M"+965BC(
X+(,%-'+9-(64'-(%5(845"*(6W59+('+$/%)(")+4/0/((,%"(<+*(%5-+5"*=("7%<'*+"(<W+9*+./<+(6+*(849*5<-%-'49*R(
X+($G(64'-(*5'?"+(<+(*879%"'4(7-%/<'(6+(<%(,"'*+(6+("+96+]M?45*(^5*:5WT(<%(;'9(6+(<%(849*5<-%-'49R(X+("+85+'<(6+*(
64997+*(*+(;%'-(,%"(<%([(3<(3IA7/1,(\(T("+.,<'"('..76'%-+.+9-(%,"S*(<%(849*5<-%-'49R((
$45"(<'.'-+"(<%(67-+8-'49=(<+(,%-'+9-(*-%96%"6'*7(64'-(%?4'"(59(.'9'.5.(6+(8499%'**%98+(*5"(<+(:5%"-'+"(6+(
8>%:5+( 8%/'9+-( 4e( '<( '"%( 849*5<-+"( @?'*'-+( 6+*( %<+9-45"*( %?%9-( <%( 849*5<-%-'49=( ,<%9( 65( :5%"-'+"( BC=( '<( 64'-(
7A%<+.+9-(-"45?+"(59+(%6"+**+(;'8-'?+(?%<'6+(T(,"4J'.'-7(65(8%/'9+-R(
$45"(<+(,%'+.+9-(6+(<%(849*5<-%-'49=(<+(,%-'+9-(*-%96%"6'*7(+J,<':5+(:5W'<(%(45/<'7(*%(8%"-+(?'-%<+=('<(,%'+(<%(
849*5<-%-'49( +-( 6+.%96+( 59+( 4(&/77(" )(" 1%/01" :5'( *+"%( "+-45"97+( %5( 84.'-7( 6+( ,'<4-%A+( @+-( *+"-(
6W-,,(1,-,/%0")("'-$,/3/'-,/%0=(+-(6+(/%*+(6+(8%<85<(,45"(<+*("7A5<%"'*%-'49*(6+(;'9(6W%997+CR(
$%"( %'<<+5"*=( <%( 849*5<-%-'49( +*-( (0$(:/1,$+(( ?'%( 59( 6'*,4*'-';( 8%8>7=( ( 6%9*( <+( /5-=( 6W7?'-+"( <+*( ,+"-+*( 6+(
64997+*=(.%'*(*5"-45-(6+(*W%**5"+"(6+(<%(;'%/'<'-7(65($G(:5+(8+(*4'-(*5"(<%("+,"7*+9-%-'49(@?7"';'+"(:5+(<+($G(
9+( *W78%"-+( ,%*( 65( *879%"'4C( 45( *5"( <+( "+85+'<( 6+*( 64997+*R( X%( *-%96%"6'*%-'49( 7-%9-( 59( 7<7.+9-(
'96'*,+9*%/<+(T(<%(?%<'6'-7(6+(<W7-56+R(
XW+9-"+-'+9(*+"%(%9%<Y*7(T(<W%'6+(6+(8+--+(A"'<<+(,"7M7-%/<'+R(a45-+*(<+*(64997+*(:5'(9+("+9-"+"49-(,%*(6%9*(
<+(8%6"+(6+(<%(:5+*-'49(6+("+8>+"8>+(9+(*+"49-(,%*(5-'<'*7+*R((
X+*(+9"+A'*-"+.+9-*(*49-(-0%096/1+1(6S*(<%(;'9(6+(<%(849*5<-%-'49=(+-(*49-(67-"5'-*(6S*(:5+(<+*(64997+*(49-(
7-7(*%'*'+*R((
(
Evaluation(du(taux(de(détection(
Z+(-Y,+(6W7-56+=(,45"(U-"+(?%<'6+=(+J'A+(:5+(<W4/*+"?%-'49(6+*(,"%-'8'+9*(*4'-(;%'-+(+9(8496'-'49*("7+<<+*=(+-(
6498(+9(%?+5A<+R(a45-+;4'*=(,45"(6'?+"*+*("%'*49*=(<+(.76+8'9(,+5-(67-+8-+"(45(*5*,+8-+"(59(,%-'+9-(6WU-"+(
<+(,%-'+9-(*-%96%"6'*7R(X+*(.76+8'9*(,%"-'8',%9-(T(<W7-56+(*W+9A%A+9-(T(678<%"+"(*'98S"+.+9-(*W'<*(67-+8-+9-(
59($G=(+-((*+"49-(1%77/3/,+1"$+:&7/F$(6(0,(@-45*(<+*(0(.4'*C(,%"(.%'<(,45"(+*-'.+"(<+(-%5J(6+(67-+8-'49(65($GR((

J"
!"#$%&'()(Méthodologie+:+propositions+issues+du+groupe+de+pilotage()(*+,-+./"+(0123(
(
X%(,"'98',%<+(8%5*+(6+(67-+8-'49("%,,4"-7+(6%9*(<%(<'--7"%-5"+(+*-((<W'9-"4658-'49([(;4"87+(\(6W59($G(6%9*(<%(
849*5<-%-'49(6W59( ,"%-'8'+9( 9W%88+,-%9-( ,<5*(6+(945?+%5( ,%-'+9-R( c<( +*-( 6498(,"7849'*7(6+( 0(" '-1" /037&$(((
8+*(,"%-'8'+9*(6%9*(<W7-56+R(